60 Degrees Pharmaceuticals, Inc.
SXTP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,440 | $3,491 | $2,362 | $2,932 |
| - Cash | $4,116 | $1,967 | $3,452 | $1,659 |
| + Debt | $0 | $154 | $155 | $156 |
| Enterprise Value | $1,324 | $1,678 | -$935 | $1,429 |
| Revenue | $438 | $101 | $164 | $261 |
| % Growth | 333.6% | -38.3% | -37.4% | – |
| Gross Profit | -$100 | $51 | $90 | $143 |
| % Margin | -22.9% | 50.4% | 55.2% | 54.8% |
| EBITDA | -$2,292 | -$1,713 | -$1,859 | -$2,032 |
| % Margin | -523.8% | -1,696.7% | -1,136.4% | -777.3% |
| Net Income | -$2,317 | -$1,734 | -$1,877 | -$2,049 |
| % Margin | -529.5% | -1,717.7% | -1,147.4% | -783.6% |
| EPS Diluted | -0.66 | -1.25 | -1.56 | -4.5 |
| % Growth | 47.2% | 19.9% | 65.3% | – |
| Operating Cash Flow | -$2,109 | -$1,450 | -$1,597 | -$1,638 |
| Capital Expenditures | -$10 | -$47 | -$5 | -$2 |
| Free Cash Flow | -$2,119 | -$1,497 | -$1,603 | -$1,640 |